Gut check: could everyday drugs sabotage lung cancer immunotherapy?
NCT ID NCT07191171
First seen Nov 01, 2025 · Last updated May 07, 2026 · Updated 32 times
Summary
This study looks at whether certain medications that alter gut bacteria can impact how well immunotherapy works in people with advanced lung cancer. Researchers will review records from 800 adults with stage III-C or IV non-small cell lung cancer who received immunotherapy. The goal is to see if these drugs affect how long patients live without their cancer getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSBIOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Service de Pneumologie - CHU de Strasbourg - France
RECRUITINGStrasbourg, 67091, France
Contact
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.